Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73


Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.

Adam PJ, Berry J, Loader JA, Tyson KL, Craggs G, Smith P, De Belin J, Steers G, Pezzella F, Sachsenmeir KF, Stamps AC, Herath A, Sim E, O'Hare MJ, Harris AL, Terrett JA.

Mol Cancer Res. 2003 Sep;1(11):826-35.


Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.

Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.

Clin Cancer Res. 2005 Jun 15;11(12):4357-64.


Securin is overexpressed in breast cancer.

Ogbagabriel S, Fernando M, Waldman FM, Bose S, Heaney AP.

Mod Pathol. 2005 Jul;18(7):985-90.


Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors.

Wakefield L, Robinson J, Long H, Ibbitt JC, Cooke S, Hurst HC, Sim E.

Genes Chromosomes Cancer. 2008 Feb;47(2):118-26.


Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers.

Smalley MJ, Iravani M, Leao M, Grigoriadis A, Kendrick H, Dexter T, Fenwick K, Regan JL, Britt K, McDonald S, Lord CJ, Mackay A, Ashworth A.

Breast Cancer Res. 2007;9(6):R85.


The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.

Zia MK, Rmali KA, Watkins G, Mansel RE, Jiang WG.

Int J Mol Med. 2007 Oct;20(4):605-11.


Suppression of RAD21 gene expression decreases cell growth and enhances cytotoxicity of etoposide and bleomycin in human breast cancer cells.

Atienza JM, Roth RB, Rosette C, Smylie KJ, Kammerer S, Rehbock J, Ekblom J, Denissenko MF.

Mol Cancer Ther. 2005 Mar;4(3):361-8.


Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.

Gery S, Tanosaki S, Bose S, Bose N, Vadgama J, Koeffler HP.

Clin Cancer Res. 2005 May 1;11(9):3184-90.


Death-associated protein kinase loss of expression is a new marker for breast cancer prognosis.

Lévy D, Plu-Bureau G, Decroix Y, Hugol D, Rostène W, Kimchi A, Gompel A.

Clin Cancer Res. 2004 May 1;10(9):3124-30.


Promoter hypomethylation of the N-acetyltransferase 1 gene in breast cancer.

Kim SJ, Kang HS, Chang HL, Jung YC, Sim HB, Lee KS, Ro J, Lee ES.

Oncol Rep. 2008 Mar;19(3):663-8.


Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance.

Pluvinage B, Dairou J, Possot OM, Martins M, Fouet A, Dupret JM, Rodrigues-Lima F.

Biochemistry. 2007 Jun 12;46(23):7069-78. Epub 2007 May 19.


ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor alpha expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells.

Honorat M, Mesnier A, Vendrell J, Guitton J, Bieche I, Lidereau R, Kruh GD, Dumontet C, Cohen P, Payen L.

Endocr Relat Cancer. 2008 Mar;15(1):125-38. doi: 10.1677/ERC-07-0189.


Human arylamine N-acetyltransferase 1: a drug-metabolizing enzyme and a drug target?

Rodrigues-Lima F, Dairou J, Busi F, Dupret JM.

Curr Drug Targets. 2010 Jun;11(6):759-66. Review.


The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition.

Tedesco D, Zhang J, Trinh L, Lalehzadeh G, Meisner R, Yamaguchi KD, Ruderman DL, Dinter H, Zajchowski DA.

Neoplasia. 2007 Jul;9(7):601-13.


Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.

Mehta K, Fok J, Miller FR, Koul D, Sahin AA.

Clin Cancer Res. 2004 Dec 1;10(23):8068-76.


Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.

Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.

Breast Cancer Res. 2008;10(5):R82. doi: 10.1186/bcr2151. Epub 2008 Sep 30.


Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis.

Savage K, Leung S, Todd SK, Brown LA, Jones RL, Robertson D, James M, Parry S, Rodrigues Pinilla SM, Huntsman D, Reis-Filho JS.

Breast Cancer Res Treat. 2008 Jul;110(2):245-56. Epub 2007 Oct 3.

Items per page

Supplemental Content

Support Center